Addendum: sartan treatment during pregnancy.
暂无分享,去创建一个
[1] C. Garel,et al. Developmental toxicity of the angiotensin II type 1 receptor antagonists during human pregnancy: a report of 10 cases , 2005, BJOG : an international journal of obstetrics and gynaecology.
[2] J. Friedman,et al. Angiotensin II receptor antagonist treatment during pregnancy. , 2005, Birth defects research. Part A, Clinical and molecular teratology.
[3] F. Muller,et al. Fetal Toxic Effects of Angiotensin II Receptor Antagonists: Case Report and Follow-Up after Birth , 2005, The Annals of pharmacotherapy.
[4] N. Berkane,et al. Fetal toxicity of valsartan and possible reversible adverse side effects. , 2004, Birth defects research. Part A, Clinical and molecular teratology.
[5] R. Cox,et al. Defective embryogenesis with angiotensin II receptor antagonists in pregnancy , 2003, BJOG : an international journal of obstetrics and gynaecology.
[6] R. Aggarwal,et al. Losartan induced fetal toxicity , 2003, Indian journal of pediatrics.
[7] C. Schaefer. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity. , 2003, Birth defects research. Part A, Clinical and molecular teratology.
[8] J. Motte,et al. Perinatal/Neonatal Case Presentation: Neonatal Acute Renal Failure Secondary to Maternal Exposure to Telmisartan, Angiotensin II Receptor Antagonist , 2003, Journal of Perinatology.
[9] L. Wilton,et al. The safety of valsartan: results of a postmarketing surveillance study on 12 881 patients in England , 2002, Journal of Human Hypertension.
[10] A. Benachi,et al. Fetal toxic effects and angiotensin-II-receptor antagonists , 2001, The Lancet.
[11] M. Nageotte,et al. Fatal Fetal Outcome with the Combined Use of Valsartan and Atenolol , 2001, The Annals of pharmacotherapy.
[12] A. Wingen,et al. Angiotensin-II-receptor inhibitors in pregnancy , 2001, The Lancet.
[13] A. Hagiwara,et al. Losartan and fetal toxic effects , 2001, The Lancet.